Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107


Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.

Anderson LJ, Longnecker R.

Blood. 2009 Jan 1;113(1):108-16. doi: 10.1182/blood-2008-06-160937. Epub 2008 Sep 24.


Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals.

Caldwell RG, Wilson JB, Anderson SJ, Longnecker R.

Immunity. 1998 Sep;9(3):405-11.


Epstein-Barr virus LMP2A imposes sensitivity to apoptosis.

Swanson-Mungerson M, Bultema R, Longnecker R.

J Gen Virol. 2010 Sep;91(Pt 9):2197-202. doi: 10.1099/vir.0.021444-0. Epub 2010 May 19.


The effects of the Epstein-Barr virus latent membrane protein 2A on B cell function.

Merchant M, Swart R, Katzman RB, Ikeda M, Ikeda A, Longnecker R, Dykstra ML, Pierce SK.

Int Rev Immunol. 2001;20(6):805-35. Review.


Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.

Swanson-Mungerson MA, Caldwell RG, Bultema R, Longnecker R.

J Virol. 2005 Jun;79(12):7355-62.


Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.

Rovedo M, Longnecker R.

J Virol. 2008 Sep;82(17):8520-8. doi: 10.1128/JVI.00843-08. Epub 2008 Jun 25.


Epstein-Barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas.

Incrocci R, McCormack M, Swanson-Mungerson M.

J Gen Virol. 2013 May;94(Pt 5):1127-33. doi: 10.1099/vir.0.049221-0. Epub 2013 Jan 9.


Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

Vockerodt M, Wei W, Nagy E, Prouzova Z, Schrader A, Kube D, Rowe M, Woodman CB, Murray PG.

J Pathol. 2013 Aug;230(4):399-409. doi: 10.1002/path.4198.


EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.

Anderson LJ, Longnecker R.

J Gen Virol. 2008 Jul;89(Pt 7):1563-8. doi: 10.1099/vir.0.2008/001461-0.


Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.

Vrazo AC, Chauchard M, Raab-Traub N, Longnecker R.

PLoS Pathog. 2012;8(4):e1002662. doi: 10.1371/journal.ppat.1002662. Epub 2012 Apr 19.


Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma.

Shair KH, Raab-Traub N.

MBio. 2012 Sep 18;3(5). pii: e00288-12. doi: 10.1128/mBio.00288-12. Print 2012.


Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.

Engels N, Merchant M, Pappu R, Chan AC, Longnecker R, Wienands J.

J Exp Med. 2001 Aug 6;194(3):255-64.


Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.

Lin JH, Lin JY, Chou YC, Chen MR, Yeh TH, Lin CW, Lin SJ, Tsai CH.

Blood. 2015 Apr 2;125(14):2228-38. doi: 10.1182/blood-2014-08-594689. Epub 2015 Jan 28.


Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.

Kohlhof H, Hampel F, Hoffmann R, Burtscher H, Weidle UH, Hölzel M, Eick D, Zimber-Strobl U, Strobl LJ.

Blood. 2009 May 28;113(22):5506-15. doi: 10.1182/blood-2008-11-190090. Epub 2009 Apr 1.


An auto-regulatory loop for EBV LMP2A involves activation of Notch.

Anderson LJ, Longnecker R.

Virology. 2008 Feb 20;371(2):257-66. Epub 2007 Nov 5.


Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.

Incrocci R, Barse L, Stone A, Vagvala S, Montesano M, Subramaniam V, Swanson-Mungerson M.

Virology. 2017 Jan;500:96-102. doi: 10.1016/j.virol.2016.10.015. Epub 2016 Oct 25.


Supplemental Content

Support Center